Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of F2 mRNA | affects expression | 21346803
|
C044815 |
3-keto-desogestrel |
3-keto-desogestrel promotes the reaction [F2 protein results in increased expression of F3 mRNA] | increases expression|increases reaction | 11733402
|
D000255 |
Adenosine Triphosphate |
calmidazolium affects the reaction [F2 protein results in increased secretion of Adenosine Triphosphate] | affects reaction|increases secretion | 2030746
|
D000255 |
Adenosine Triphosphate |
F2 protein results in increased secretion of Adenosine Triphosphate | increases secretion | 2030746
|
D000255 |
Adenosine Triphosphate |
Fendiline affects the reaction [F2 protein results in increased secretion of Adenosine Triphosphate] | affects reaction|increases secretion | 2030746
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of F2 protein | affects expression | 20106945
|
D000638 |
Amiodarone |
Amiodarone inhibits the reaction [F2 protein results in increased expression of and results in increased activity of F3 protein] | decreases reaction|increases activity|increases expression | 18974383
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of F2 mRNA | affects expression | 16483693
|
D000661 |
Amphetamine |
Amphetamine promotes the reaction [F2 protein results in increased expression of F3 protein] | increases expression|increases reaction | 20118172
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased expression of F3 protein] | affects cotreatment|decreases reaction|increases expression | 19944065
|
C031942 |
argatroban |
argatroban binds to and results in decreased activity of F2 protein | affects binding|decreases activity | 15080313 16084352 18449412
|
D001218 |
Aspartame |
Aspartame analog results in decreased activity of F2 protein | decreases activity | 15572260
|
D001218 |
Aspartame |
Aspartame results in decreased activity of F2 protein | decreases activity | 15572260
|
C111479 |
BCH 2763 |
BCH 2763 results in decreased activity of F2 protein | decreases activity | 9684808
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of F2 mRNA | increases expression | 20440473
|
C095105 |
bexarotene |
bexarotene results in decreased expression of F2 mRNA | decreases expression | 16648578
|
C074619 |
bivalirudin |
bivalirudin binds to and results in decreased activity of F2 protein | affects binding|decreases activity | 18449412 17696810 15155122 15080313 16084352 19124943
|
C074619 |
bivalirudin |
bivalirudin inhibits the reaction [F2 protein results in increased expression of SELP protein] | decreases reaction|increases expression | 16845256
|
C074619 |
bivalirudin |
bivalirudin results in decreased activity of F2 protein | decreases activity | 8456428 1290488 19644995
|
C074619 |
bivalirudin |
F2 protein results in increased cleavage of bivalirudin | increases cleavage | 1290488
|
C074619 |
bivalirudin |
bivalirudin inhibits the reaction [F2 protein results in increased expression of SERPINE1 mRNA] | decreases reaction|increases expression | 9125671 9579636
|
C074619 |
bivalirudin |
bivalirudin inhibits the reaction [F2 protein results in increased expression of SERPINE1 protein] | decreases reaction|increases expression | 9579636
|
C074619 |
bivalirudin |
bivalirudin inhibits the reaction [F2 protein results in increased secretion of SERPINE1 protein] | decreases reaction|increases secretion | 9125671
|
D015124 |
8-Bromo Cyclic Adenosine Monophosphate |
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [F2 protein results in increased expression of SERPINE1 protein] | decreases reaction|increases expression | 9579636
|
C031938 |
calmidazolium |
calmidazolium affects the reaction [F2 protein results in increased secretion of Adenosine Triphosphate] | affects reaction|increases secretion | 2030746
|
D002211 |
Capsaicin |
Capsaicin affects the expression of F2 protein | affects expression | 8285224
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased activity of F2 protein | increases activity | 12297134
|
C086276 |
cerivastatin |
cerivastatin inhibits the reaction [F2 protein results in decreased expression of ENTPD1 protein] | decreases expression|decreases reaction | 12067895
|
D002713 |
Chlorine |
Chlorine results in decreased expression of F2 mRNA | decreases expression | 18636392
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] affects the expression of F2 mRNA | affects cotreatment|affects expression | 18636392
|
C055162 |
clopidogrel |
clopidogrel inhibits the reaction [F2 protein results in increased expression of SELP protein] | decreases reaction|increases expression | 17043144
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [F2 protein results in increased expression of ITGA2B protein] | decreases reaction|increases expression | 18565277
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [F2 protein results in increased expression of ITGB3 protein] | decreases reaction|increases expression | 18565277
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [F2 protein results in increased expression of SELE protein] | decreases reaction|increases expression | 18565277
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [F2 protein results in increased expression of SELP protein] | decreases reaction|increases expression | 18565277
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of F2 mRNA | decreases expression | 20106945
|
D003871 |
Dermatan Sulfate |
[Dermatan Sulfate co-treated with SERPIND1 protein] results in decreased activity of F2 protein | affects cotreatment|decreases activity | 11805133
|
D003907 |
Dexamethasone |
Dexamethasone promotes the reaction [F2 protein results in increased expression of F3 mRNA] | increases expression|increases reaction | 11733402
|
D003907 |
Dexamethasone |
Dexamethasone promotes the reaction [F2 protein results in increased expression of F3 mRNA] | increases expression|increases reaction | 11733402
|
C023635 |
dienogest |
[Ethinyl Estradiol co-treated with dienogest] results in increased expression of F2 protein | affects cotreatment|increases expression | 15288212
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate inhibits the reaction [F2 protein results in increased activity of F3 protein] | decreases reaction|increases activity | 19944065
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate inhibits the reaction [F2 protein results in increased expression of F3 mRNA] | decreases reaction|increases expression | 19944065
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate inhibits the reaction [F2 protein results in increased expression of F3 protein] | decreases reaction|increases expression | 19944065
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased activity of F3 protein] | affects cotreatment|decreases reaction|increases activity | 19944065
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased expression of F3 mRNA] | affects cotreatment|decreases reaction|increases expression | 19944065
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased expression of F3 protein] | affects cotreatment|decreases reaction|increases expression | 19944065
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK8 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19944065
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK9 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19944065
|
C454300 |
estradiol valerate-dienogest |
[Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in increased expression of F2 protein | affects cotreatment|increases expression | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with dienogest] results in increased expression of F2 protein | affects cotreatment|increases expression | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in increased expression of F2 protein | affects cotreatment|increases expression | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of F2 protein | affects cotreatment|decreases activity | 16522526
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in decreased expression of F2 protein | affects cotreatment|decreases expression | 15504374
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of F2 mRNA | affects cotreatment|decreases expression | 17942748
|
D005275 |
Fendiline |
Fendiline affects the reaction [F2 protein results in increased secretion of Adenosine Triphosphate] | affects reaction|increases secretion | 2030746
|
C025314 |
ferric citrate |
ferric citrate results in decreased activity of F2 protein | decreases activity | 6421970
|
C020748 |
ferrous sulfate |
ferrous sulfate results in decreased activity of F2 protein | decreases activity | 6421970
|
D005472 |
Fluorouracil |
Fluorouracil results in decreased expression of F2 mRNA | decreases expression | 16709241
|
D005576 |
Forskolin |
Forskolin inhibits the reaction [F2 protein results in increased expression of SERPINE1 protein] | decreases reaction|increases expression | 9579636
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of F2 protein | affects cotreatment|decreases activity | 16522526
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in decreased expression of F2 protein | affects cotreatment|decreases expression | 15504374
|
D006493 |
Heparin |
Heparin inhibits the reaction [F2 protein results in increased cleavage of F2R protein] | decreases reaction|increases cleavage | 19468011
|
D007501 |
Iron |
Iron results in decreased activity of F2 protein | decreases activity | 6421970
|
C083544 |
lepirudin |
lepirudin binds to and results in decreased activity of F2 protein | affects binding|decreases activity | 15080313 18449412
|
D017258 |
Medroxyprogesterone Acetate |
Medroxyprogesterone Acetate promotes the reaction [F2 protein results in increased expression of F3 mRNA] | increases expression|increases reaction | 11733402
|
D017258 |
Medroxyprogesterone Acetate |
Medroxyprogesterone Acetate promotes the reaction [F2 protein results in increased expression of F3 mRNA] | increases expression|increases reaction | 11733402
|
C109573 |
melagatran |
melagatran binds to and results in decreased activity of F2 protein | affects binding|decreases activity | 16084352
|
C025589 |
ochratoxin A |
ochratoxin A results in decreased expression of F2 mRNA | decreases expression | 16251485
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] affects the expression of F2 mRNA | affects cotreatment|affects expression | 18636392
|
D017239 |
Paclitaxel |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased expression of F3 protein] | affects cotreatment|decreases reaction|increases expression | 19944065
|
D017239 |
Paclitaxel |
epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased activity of F3 protein] | affects cotreatment|decreases reaction|increases activity | 19944065
|
D017239 |
Paclitaxel |
epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased expression of F3 mRNA] | affects cotreatment|decreases reaction|increases expression | 19944065
|
D017239 |
Paclitaxel |
epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased expression of F3 protein] | affects cotreatment|decreases reaction|increases expression | 19944065
|
D017239 |
Paclitaxel |
epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK8 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19944065
|
D017239 |
Paclitaxel |
epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK9 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19944065
|
D017239 |
Paclitaxel |
[Paclitaxel co-treated with F2 protein] affects the localization of RELA protein | affects cotreatment|affects localization | 19944065
|
D017239 |
Paclitaxel |
[Paclitaxel co-treated with F2 protein] results in increased activity of F3 protein | affects cotreatment|increases activity | 19944065
|
D017239 |
Paclitaxel |
[Paclitaxel co-treated with F2 protein] results in increased expression of F3 mRNA | affects cotreatment|increases expression | 19944065
|
D017239 |
Paclitaxel |
[Paclitaxel co-treated with F2 protein] results in increased expression of F3 protein | affects cotreatment|increases expression | 19944065
|
D017239 |
Paclitaxel |
[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK8 protein | affects cotreatment|increases phosphorylation | 19944065
|
D017239 |
Paclitaxel |
[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK9 protein | affects cotreatment|increases phosphorylation | 19944065
|
C020924 |
phenylalanyl-prolyl-arginine methyl chloride |
phenylalanyl-prolyl-arginine methyl chloride inhibits the reaction [F2 protein results in increased expression of FOS mRNA] | decreases reaction|increases expression | 18597608
|
C020924 |
phenylalanyl-prolyl-arginine methyl chloride |
phenylalanyl-prolyl-arginine methyl chloride inhibits the reaction [F2 protein results in increased expression of MYC mRNA] | decreases reaction|increases expression | 18597608
|
C060974 |
phosphatidylinositol 3,4,5-triphosphate |
F2 protein results in increased abundance of phosphatidylinositol 3,4,5-triphosphate | increases abundance | 16051184
|
C060974 |
phosphatidylinositol 3,4,5-triphosphate |
resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 3,4,5-triphosphate] | decreases reaction|increases abundance | 16051184
|
C060980 |
phosphatidylinositol 3,4-diphosphate |
F2 protein results in increased abundance of phosphatidylinositol 3,4-diphosphate | increases abundance | 16051184
|
C060980 |
phosphatidylinositol 3,4-diphosphate |
resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 3,4-diphosphate] | decreases reaction|increases abundance | 16051184
|
C037178 |
phosphatidylinositol 4-phosphate |
F2 protein results in increased abundance of phosphatidylinositol 4-phosphate | increases abundance | 16051184
|
C037178 |
phosphatidylinositol 4-phosphate |
resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 4-phosphate] | decreases reaction|increases abundance | 16051184
|
D010716 |
Phosphatidylinositols |
F2 protein results in increased abundance of Phosphatidylinositols | increases abundance | 16051184
|
D010716 |
Phosphatidylinositols |
resveratrol inhibits the reaction [F2 protein results in increased abundance of Phosphatidylinositols] | decreases reaction|increases abundance | 16051184
|
D019269 |
Phosphatidylinositol 4,5-Diphosphate |
F2 protein results in increased abundance of Phosphatidylinositol 4,5-Diphosphate | increases abundance | 16051184
|
D019269 |
Phosphatidylinositol 4,5-Diphosphate |
resveratrol inhibits the reaction [F2 protein results in increased abundance of Phosphatidylinositol 4,5-Diphosphate] | decreases reaction|increases abundance | 16051184
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [F2 protein results in increased expression of SELP protein] | decreases reaction|increases expression | 14628445
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 3,4,5-triphosphate] | decreases reaction|increases abundance | 16051184
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 3,4-diphosphate] | decreases reaction|increases abundance | 16051184
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [F2 protein results in increased abundance of Phosphatidylinositol 4,5-Diphosphate] | decreases reaction|increases abundance | 16051184
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 4-phosphate] | decreases reaction|increases abundance | 16051184
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [F2 protein results in increased abundance of Phosphatidylinositols] | decreases reaction|increases abundance | 16051184
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [F2 protein results in increased expression of SELP protein] | decreases reaction|increases expression | 16051184
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [F2 protein results in increased phosphorylation of PLEK protein] | decreases reaction|increases phosphorylation | 16051184
|
D019821 |
Simvastatin |
Simvastatin inhibits the reaction [F2 protein results in decreased expression of ENTPD1 protein] | decreases expression|decreases reaction | 12067895
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of F2 mRNA | affects cotreatment|decreases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of F2 mRNA | increases expression | 16267337
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of F2 mRNA | increases expression | 15644576
|
C524038 |
variegin protein, Amblyomma variegatum |
F2 protein results in increased cleavage of variegin protein, Amblyomma variegatum | increases cleavage | 19644995
|
C524038 |
variegin protein, Amblyomma variegatum |
variegin protein, Amblyomma variegatum binds to and results in decreased activity of F2 protein | affects binding|decreases activity | 19644995
|
D014859 |
Warfarin |
F2 gene polymorphism affects the susceptibility to Warfarin | affects response to substance | 14656880
|
C426686 |
ximelagatran |
ximelagatran binds to and results in decreased activity of F2 protein | affects binding|decreases activity | 16084352 15155122
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Capsaicin |
6.78 | 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
6.78 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.98 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.35 | 17505938 |
MESH:D054058 |
Acute Coronary Syndrome |
|
bivalirudin |
11.45 | 19804226 10629409 |
MESH:D054058 |
Acute Coronary Syndrome |
|
clopidogrel |
11.45 | 19106084 |
MESH:D058186 |
Acute Kidney Injury |
|
Capsaicin |
7.37 | 18460982 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
7.37 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
3.79 | 20601635 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
5.95 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
5.95 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
5.95 | 17638652 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
5.59 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
5.59 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
2.80 | 16835633 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.49 | 17887948 |
MESH:D000505 |
Alopecia |
|
Capsaicin |
4.26 | 17569567 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
5.07 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
8.06 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
8.06 | 16563566 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
8.06 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
8.06 | 16162502 16183991 |
MESH:D019969 |
Amphetamine-Related Disorders |
|
Amphetamine |
5.47 | 16459022 15010207 18475255 16916582 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
11.95 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Iron |
11.95 | 16434484 16566752 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
11.95 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.72 | 17084956 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
4.14 | 17375513 17162259 17163184 16569441 17147795 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Aspartame |
5.50 | 11372003 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
4.29 | 16910769 |
MESH:D000787 |
Angina Pectoris |
|
Fendiline |
6.31 | 12088766 |
MESH:D000855 |
Anorexia |
|
Amphetamine |
4.50 | 16084549 16101753 12005258 12183048 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.50 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
7.55 | 20041841 18218290 18057881 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
7.55 | 16604332 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
2.90 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
10.11 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
10.11 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
10.11 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Aspartame |
6.65 | 10777254 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
6.65 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
6.65 | 15570426 |
MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
4.61 | 16516891 |
MESH:D001249 |
Asthma |
|
Ozone |
4.61 | 16373670 17854713 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
11.17 | 15336622 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
11.17 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
9.01 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
9.01 | 16632123 16640825 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
9.01 | 17967414 16873680 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.46 | 19698954 18651412 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.87 | 17352947 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
14.89 | 19761891 |
MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
14.89 | 19761891 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
14.89 | 19761891 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
4.61 | 16640825 |
MESH:D001778 |
Blood Coagulation Disorders |
marker/mechanism |
|
| 17721328 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
12.57 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
ferrous sulfate |
12.57 | 6421970 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
12.57 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.20 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.37 | 15746008 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.03 | 15867366 |
MESH:D001919 |
Bradycardia |
|
Capsaicin |
4.48 | 18207255 |
MESH:D002545 |
Brain Ischemia |
marker/mechanism |
|
| 14753426 |
MESH:D002545 |
Brain Ischemia |
|
Capsaicin |
13.82 | 19211983 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
13.82 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
13.82 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
3.43 | 17596214 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
5.04 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
5.04 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
5.04 | 19250217 18462866 18593918 16243823 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
5.04 | 16110121 16595493 19217205 18357371 15136595 16557594 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
ochratoxin A |
5.04 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
5.04 | 15136595 11325840 18323546 16115903 16273361 18223236 16244791 18234424 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
5.04 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
5.04 | 17534123 16393696 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.04 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.21 | 18315731 14754758 17626835 15516495 18417511 16777450 19059883 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.16 | 16183385 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.95 | 16962696 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.21 | 16050911 16227642 16011737 15673190 16192424 15700767 18705752 15721981 3786805 10355542 16097048 16124888 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.07 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
11.26 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
11.26 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
11.26 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
14.65 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
14.65 | 12907637 12619106 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
14.65 | 19418558 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
14.65 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
14.65 | 17045692 18930000 16332177 17088986 16799960 17971768 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
14.65 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
14.65 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
14.65 | 19321006 16227395 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.01 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
5.05 | 16247446 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
5.05 | 18414057 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.38 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
2.72 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
9.08 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
9.08 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
9.08 | 17066447 16757204 18986760 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
9.08 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
5.63 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
5.63 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
3.64 | 16640825 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
5.37 | 15710769 19225199 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
5.37 | 16604332 |
MESH:D002318 |
Cardiovascular Diseases |
|
clopidogrel |
6.60 | 20180610 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.60 | 15458977 |
MESH:D020212 |
Carotid Artery Injuries |
|
bivalirudin |
6.02 | 11316950 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.50 | 18974383 |
MESH:D002386 |
Cataract |
|
Adenosine Triphosphate |
7.31 | 15003327 |
MESH:D002386 |
Cataract |
|
Simvastatin |
7.31 | 12518039 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
5.19 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
5.19 | 12371664 |
MESH:D002543 |
Cerebral Hemorrhage |
|
Warfarin |
5.29 | 11061249 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.67 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
6.30 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.30 | 16919318 17110522 16105132 15861022 17681005 17333356 11677210 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.83 | 16354765 15340226 12621046 15668235 8697196 |
MESH:D003092 |
Colitis |
|
Curcumin |
7.91 | 16782535 16804969 18200517 |
MESH:D003092 |
Colitis |
|
resveratrol |
7.91 | 16474422 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.02 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
12.16 | 16340194 19359593 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
12.16 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
12.16 | 17287894 17725105 17172411 15001691 16340194 16510598 17018589 17016597 18772588 17169374 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
12.16 | 16640825 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
12.16 | 11134977 16640504 17191121 19440933 19056647 15741050 17148506 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
12.16 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
4.22 | 17454858 18949393 18802399 16391804 18383874 18288408 15148649 17016601 17695437 18448328 16282729 17401013 16303861 14970324 16524972 17255274 18509181 15289873 20501625 17594712 17094418 16331619 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
4.22 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
4.22 | 18852136 18095365 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
4.22 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.57 | 17141729 14669216 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.33 | 18497527 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.36 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
Warfarin |
5.12 | 12872399 |
MESH:D003328 |
Coronary Thrombosis |
|
bivalirudin |
5.22 | 18036681 |
MESH:D003371 |
Cough |
|
Capsaicin |
4.58 | 10350223 |
OMIM:122700 |
COUMARIN RESISTANCE |
|
Warfarin |
5.28 | 20579077 20497562 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
3.52 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
ochratoxin A |
3.52 | 20036863 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.52 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.45 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Simvastatin |
4.44 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.21 | 16733453 |
MESH:D003731 |
Dental Caries |
|
Aspartame |
6.33 | 8955999 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Aspartame |
5.91 | 14996049 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
5.91 | 12438553 |
MESH:D048909 |
Diabetes Complications |
|
bivalirudin |
5.76 | 18436116 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
3.96 | 16640825 16604332 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
6.96 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
6.96 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
5.55 | 16506275 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Warfarin |
5.55 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
8.80 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
8.80 | 16988119 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
8.80 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
8.80 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
12.46 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
12.46 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Warfarin |
12.46 | 12644472 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.16 | 7237001 |
MESH:D003875 |
Drug Eruptions |
|
Warfarin |
5.41 | 14723717 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
7.22 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
7.22 | 18218290 15265979 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
7.22 | 7179309 21278145 7120509 10915739 10092053 17522070 15998439 16227642 15027814 7440962 3786805 9327722 6884620 2869522 6623471 4309450 11566570 19085960 3732212 16177239 19336974 15968718 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
7.22 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.32 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Capsaicin |
7.79 | 11535926 10671773 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
7.79 | 17351913 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
4.03 | 20016425 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.91 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
8.58 | 19703484 |
MESH:D004487 |
Edema |
|
resveratrol |
8.58 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
8.58 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.31 | 15322242 18230668 16714409 |
MESH:D016769 |
Embolism and Thrombosis |
|
argatroban |
26.77 | 16084352 |
MESH:D016769 |
Embolism and Thrombosis |
|
BCH 2763 |
26.77 | 9684808 |
MESH:D016769 |
Embolism and Thrombosis |
|
bivalirudin |
26.77 | 16084352 |
MESH:D016769 |
Embolism and Thrombosis |
|
melagatran |
26.77 | 16084352 |
MESH:D016769 |
Embolism and Thrombosis |
|
ximelagatran |
26.77 | 16084352 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
7.29 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
7.29 | 17872969 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.52 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.28 | 17923197 |
MESH:D004893 |
Erythema Nodosum |
|
Aspartame |
6.33 | 9324739 |
MESH:D004935 |
Esophageal Diseases |
|
Capsaicin |
5.12 | 19566590 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
6.22 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
6.22 | 15173087 17638652 16337965 16785472 16481741 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
6.22 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.57 | 11564622 |
MESH:D005141 |
Eyelid Diseases |
|
Aspartame |
5.78 | 14996049 |
MESH:D005221 |
Fatigue |
|
Amphetamine |
5.02 | 19890266 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
23.98 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
23.98 | 16045604 12631006 19224547 12795759 61145 15959796 17595544 16239168 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
23.98 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
23.98 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
23.98 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Iron |
23.98 | 16640825 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.89 | 11858732 |
MESH:D005334 |
Fever |
|
Aspartame |
4.82 | 9630831 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
21.74 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
21.74 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
21.74 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
21.74 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
21.74 | 20067830 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
4.86 | 16604332 16640825 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
4.42 | 20016425 |
MESH:D006471 |
Gastrointestinal Hemorrhage |
|
Warfarin |
6.12 | 11794436 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.12 | 18462866 |
MESH:D005776 |
Gaucher Disease |
|
Warfarin |
5.40 | 12359135 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.63 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Capsaicin |
9.80 | 18405923 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
9.80 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
9.80 | 19804834 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
5.29 | 16145905 |
MESH:D005910 |
Glioma |
|
Quercetin |
5.29 | 17643826 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.00 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
6.60 | 18462866 18829502 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
6.60 | 15102660 18337622 15162350 |
MESH:D006356 |
Heartburn |
|
Capsaicin |
5.12 | 19566590 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.32 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.32 | 10048152 11294989 |
MESH:D006406 |
Hematoma |
|
Warfarin |
6.12 | 17493413 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
4.05 | 17053826 16640825 16604332 16574947 17255318 17236123 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.84 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
bivalirudin |
14.56 | 19147609 16125490 18436116 19281522 19360860 16598112 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
14.56 | 11000095 |
MESH:D006470 |
Hemorrhage |
|
Warfarin |
14.56 | 18429757 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
4.62 | 16604332 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.05 | 19900420 19110552 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
4.87 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
4.37 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
11.32 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
11.32 | 16890145 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
11.32 | 15340226 16120746 12621046 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.47 | 17701891 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.84 | 7520565 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.60 | 16876885 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.34 | 16597321 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.45 | 8697196 16959395 15340226 18606429 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Capsaicin |
3.87 | 17434803 17043245 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.95 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
12.38 | 8137927 9751232 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
12.38 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
12.38 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
3.52 | 11834736 18262572 |
MESH:D006948 |
Hyperkinesis |
|
Amphetamine |
4.85 | 14960337 1977408 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.49 | 16873680 |
MESH:D006938 |
Hyperlipoproteinemia Type II |
|
Simvastatin |
4.74 | 16238680 |
MESH:D006973 |
Hypertension |
|
Aspartame |
13.64 | 18708962 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
13.64 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
13.64 | 17042910 |
MESH:D006973 |
Hypertension |
|
Quercetin |
13.64 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
13.64 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.52 | 15338365 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Warfarin |
4.38 | 12359135 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.79 | 17488730 |
MESH:D007006 |
Hypogonadism |
|
Iron |
3.98 | 16640825 |
MESH:D007020 |
Hypoprothrombinemias |
marker/mechanism |
|
| |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.24 | 16945680 16569931 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
9.79 | 17991464 18020914 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
9.79 | 16640825 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.08 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.92 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.09 | 17937319 |
MESH:D007249 |
Inflammation |
|
bivalirudin |
15.64 | 16125490 |
MESH:D007249 |
Inflammation |
|
Capsaicin |
15.64 | 16956363 |
MESH:D007249 |
Inflammation |
|
Curcumin |
15.64 | 18403477 16956363 17151092 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
15.64 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
resveratrol |
15.64 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
15.64 | 12200463 12878042 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
2.94 | 18596194 18200517 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
9.22 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
9.22 | 16624496 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.71 | 10783313 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
4.50 | 17163184 |
MESH:D007511 |
Ischemia |
|
bivalirudin |
5.45 | 18436116 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.81 | 16580747 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.38 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.85 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Aspartame |
11.63 | 11409539 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
11.63 | 10903974 18776723 8314463 |
MESH:D007674 |
Kidney Diseases |
|
ochratoxin A |
11.63 | 11409539 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
11.63 | 16962696 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
13.91 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.91 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
13.91 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
ochratoxin A |
13.91 | 16251485 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
4.03 | 18555241 |
MESH:D007938 |
Leukemia |
|
Curcumin |
5.56 | 18462866 |
MESH:D007938 |
Leukemia |
|
Quercetin |
5.56 | 17468513 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
3.68 | 16106398 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
4.79 | 16972261 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.18 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
4.21 | 16106398 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
4.86 | 16563566 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.08 | 15342952 17567588 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.28 | 17353645 |
MESH:D054068 |
Livedo Reticularis |
|
Warfarin |
6.12 | 18280355 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
5.78 | 16943688 17157831 11408273 21278145 11903743 16221502 17174718 17334410 16239168 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
5.78 | 16640825 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
9.37 | 18006644 11481614 18277467 17900296 17922224 15052691 15925388 18472332 18054572 16097048 12632514 14716833 12445418 18418968 18251166 15650968 16015684 16027843 18376398 12667390 17805973 12958196 15730626 14724832 15931870 12609069 15338365 18395095 17708605 15123356 17714472 12445421 16248980 17640975 14716496 15362042 17761835 17766677 15673190 15959796 14512876 18317297 15370692 20821823 12666154 16192424 17823541 18187930 16638106 17565644 18210741 18420326 17698563 17481882 12389079 18339082 14620537 12586293 12546737 16116963 18395914 18481824 17557913 18429990 17721639 17944888 12898905 15893842 18279442 12741479 18412020 12632512 15818738 15996030 10355542 16011737 13678700 16136751 18205269 18705752 17869086 12649538 17525996 18472094 16033810 18263696 18166357 17976157 15057751 18156304 14748882 15876570 17631135 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
9.37 | 17355460 18705752 18006644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
9.37 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
9.37 | 17481882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Heparin |
9.37 | 16904936 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
9.37 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
9.37 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Capsaicin |
5.65 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
5.65 | 17285989 15720792 16246199 16964402 15830285 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
5.65 | 16956363 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
4.44 | 17207112 16737972 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.59 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.18 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
24.94 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
24.94 | 2125692 15890375 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
24.94 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
24.94 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
24.94 | 16603448 17045692 15113037 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
24.94 | 20302851 16640825 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
24.94 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
24.94 | 19073162 19812893 20405173 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
24.94 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.55 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
14.55 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
14.55 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
14.55 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.55 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.13 | 17391786 11989578 15350150 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
6.23 | 12587719 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
6.23 | 8266340 19066396 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
3.89 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.29 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
15.68 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
15.68 | 18520028 6695378 20464547 20064080 18569708 20135361 18816296 20869020 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
15.68 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
15.68 | 19359593 18462866 16243823 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
15.68 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
15.68 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
15.68 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
15.68 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
15.68 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
15.68 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.21 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
3.16 | 18462866 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.76 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
7.39 | 14749477 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
7.39 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
4.12 | 16173963 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.58 | 11161223 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.63 | 16640825 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.67 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
8.03 | 19196722 19196723 15591091 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
ochratoxin A |
8.03 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
8.03 | 8985016 11606380 |
MESH:D008545 |
Melanoma |
|
Curcumin |
6.26 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
6.26 | 11746506 17992120 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
6.26 | 16342250 12025231 12040289 |
MESH:D008545 |
Melanoma |
|
resveratrol |
6.26 | 17992120 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
3.60 | 17263510 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.85 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.19 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.51 | 10496685 |
MESH:D008850 |
Microphthalmos |
|
ochratoxin A |
5.24 | 20036863 |
MESH:D008881 |
Migraine Disorders |
|
Aspartame |
4.46 | 18627677 10792367 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
7.01 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
7.01 | 16757204 18986760 |
MESH:D009101 |
Multiple Myeloma |
|
Capsaicin |
18.15 | 17505005 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
18.15 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
18.15 | 15744524 15867202 16118317 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
18.15 | 14749477 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
18.15 | 14749477 17164350 16267019 16490592 17935668 17049120 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
5.08 | 17086897 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
17.78 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
17.78 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
17.78 | 17962980 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
11.16 | 17974566 12754197 |
MESH:D009181 |
Mycoses |
|
Iron |
11.16 | 16640825 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
3.18 | 9809623 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
5.12 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.12 | 17188708 16456233 16525036 16317513 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
bivalirudin |
18.09 | 10562259 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
18.09 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
18.09 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
18.09 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
7.41 | 16604332 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
7.41 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.18 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.03 | 7678174 18551238 |
MESH:D009336 |
Necrosis |
|
Warfarin |
9.03 | 14723717 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
3.82 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
clopidogrel |
5.68 | 11875746 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
5.68 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Aspartame |
9.33 | 16507461 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
9.33 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
9.33 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
9.33 | 15185748 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.44 | 8985016 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
9.16 | 19196722 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
9.16 | 12497104 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.85 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
7.84 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
7.84 | 17178036 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
2.66 | 14600291 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.03 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
ochratoxin A |
4.05 | 20036863 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Amphetamine |
11.64 | 15183010 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
11.64 | 17296847 16604332 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
11.64 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
Capsaicin |
14.80 | 17961222 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
14.80 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
14.80 | 17929310 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.03 | 16436463 |
MESH:D009765 |
Obesity |
|
Capsaicin |
4.57 | 19056576 |
MESH:D009765 |
Obesity |
|
Curcumin |
4.57 | 19297423 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
2.93 | 16049721 |
MESH:D010003 |
Osteoarthritis |
|
Aspartame |
7.17 | 9630831 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
7.17 | 16640825 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.40 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
6.31 | 18719352 |
MESH:D010024 |
Osteoporosis |
|
Iron |
6.31 | 16640825 16648989 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
8.41 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
8.41 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
9.58 | 18462866 19020741 |
MESH:D010051 |
Ovarian Neoplasms |
|
Medroxyprogesterone Acetate |
9.58 | 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
9.58 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
9.58 | 19005980 |
MESH:D010146 |
Pain |
|
Aspartame |
6.27 | 9630831 |
MESH:D010146 |
Pain |
|
Capsaicin |
6.27 | 17084039 16996476 17043245 17434803 19081190 18987195 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
7.30 | 17440100 19196508 19401701 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
7.30 | 16929163 15113037 19003803 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
7.30 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.15 | 11578682 |
MESH:D010212 |
Papilloma |
|
Iron |
3.92 | 12065085 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.42 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
3.08 | 16563566 16640825 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.65 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.57 | 16369182 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
5.08 | 16604332 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.81 | 18929643 18007984 18381685 |
MESH:D011041 |
Poisoning |
|
Iron |
3.76 | 16604332 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
Simvastatin |
4.83 | 17105841 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
9.18 | 16640825 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
9.18 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
7.46 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
7.46 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.19 | 21297632 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
3.97 | 16640825 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
7.66 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
7.66 | 11222880 11118676 11399792 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.88 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
1.88 | 11398177 18226269 15129424 12497104 18156803 10851300 18769126 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
1.88 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
1.88 | 16356831 17172428 17136230 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
1.88 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
1.88 | 16731767 15767336 17675339 17718901 17636462 17804756 |
MESH:D020151 |
Protein C Deficiency |
|
Warfarin |
5.76 | 18376272 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.42 | 16640825 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.74 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.00 | 16882103 |
MESH:D011655 |
Pulmonary Embolism |
|
Warfarin |
5.76 | 19300499 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
4.02 | 19168576 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.60 | 11597910 12832656 12490602 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.51 | 18286688 15538739 18722050 16160472 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.99 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
Capsaicin |
6.09 | 18460982 19211983 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.09 | 16314181 17520802 16317513 17058453 15827377 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
4.62 | 18579056 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
7.52 | 18379247 10666014 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
7.52 | 11700416 18379247 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.28 | 18990726 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
4.10 | 16930377 |
MESH:D012170 |
Retinal Vein Occlusion |
|
clopidogrel |
5.55 | 19371211 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
3.61 | 18462866 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.95 | 16862918 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.15 | 18551238 |
MESH:D018805 |
Sepsis |
|
Curcumin |
3.59 | 18389075 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.50 | 18724381 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
marker/mechanism |
|
| 12269725 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Heparin |
10.91 | 12269725 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Warfarin |
10.91 | 12269725 |
MESH:D012859 |
Sjogren's Syndrome |
|
Aspartame |
5.98 | 16800424 |
MESH:D017445 |
Skin Diseases, Vascular |
marker/mechanism |
|
| 17535202 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
11.05 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
11.05 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
11.05 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
11.05 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.35 | 16709447 |
MESH:D019956 |
Stereotypic Movement Disorder |
|
Amphetamine |
5.83 | 1977408 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.74 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.03 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.03 | 16424979 19084572 18396642 17498489 17522103 16951190 18567086 19015929 17172411 15786421 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
3.03 | 18506536 18396642 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
9.17 | 18087811 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
9.17 | 16631530 19188055 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
9.17 | 15138204 |
MESH:D020521 |
Stroke |
marker/mechanism |
|
| |
MESH:D020521 |
Stroke |
|
bivalirudin |
8.28 | 14683561 |
MESH:D020521 |
Stroke |
|
Warfarin |
8.28 | 19300499 |
OMIM:601367 |
STROKE, ISCHEMIC |
marker/mechanism |
|
| |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.97 | 16321402 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
4.87 | 16640825 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
3.74 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
3.64 | 19225199 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.23 | 16930453 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Capsaicin |
5.13 | 17997062 |
MESH:D013921 |
Thrombocytopenia |
|
argatroban |
19.14 | 16893407 |
MESH:D013921 |
Thrombocytopenia |
|
Aspartame |
19.14 | 17534100 |
MESH:D013921 |
Thrombocytopenia |
|
bivalirudin |
19.14 | 16651880 16893407 |
MESH:D013921 |
Thrombocytopenia |
|
Heparin |
19.14 | 16893407 16651880 |
MESH:D013923 |
Thromboembolism |
|
Warfarin |
5.57 | 18698879 16960144 |
MESH:D019851 |
Thrombophilia |
marker/mechanism |
|
| |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
15.33 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Gestodene |
15.33 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Warfarin |
15.33 | 17493413 |
MESH:D013927 |
Thrombosis |
marker/mechanism |
|
| 17245631 |
MESH:D013927 |
Thrombosis |
|
argatroban |
34.93 | 14593979 16893407 |
MESH:D013927 |
Thrombosis |
|
bivalirudin |
34.93 | 8456428 16893407 15979436 9125671 14593979 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
34.93 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Gestodene |
34.93 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Heparin |
34.93 | 16893407 |
MESH:D013927 |
Thrombosis |
|
lepirudin |
34.93 | 14593979 |
MESH:D013927 |
Thrombosis |
|
Warfarin |
34.93 | 19300499 11518727 17672075 17245631 11307788 15720958 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
10.07 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
10.07 | 12697716 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.29 | 18020914 19584973 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
8.29 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.29 | 16227395 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
3.61 | 17467628 11989578 |
MESH:D014376 |
Tuberculosis |
|
Iron |
3.70 | 16597321 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
9.75 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
9.75 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
9.75 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
9.75 | 16720314 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.68 | 18462866 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
3.73 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
7.92 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
7.92 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
7.66 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
7.66 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
9.79 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
9.79 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.00 | 12125929 |
MESH:D014657 |
Vasculitis |
|
Heparin |
10.91 | 20337814 |
MESH:D014657 |
Vasculitis |
|
Warfarin |
10.91 | 20337814 |
MESH:D054556 |
Venous Thromboembolism |
|
Warfarin |
5.77 | 18776969 |
MESH:D020246 |
Venous Thrombosis |
marker/mechanism |
|
| 12296757 19920886 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
9.00 | 14671159 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
Warfarin |
9.00 | 14723717 15733061 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.73 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.65 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.85 | 17120751 |